Otsuka Pharmaceutical Factory Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Otsuka Pharmaceutical Factory Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014081
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Otsuka Pharmaceutical Factory Inc (Otsuka), a subsidiary of Otsuka Holdings Co Ltd is a provider of parenteral and enteral nutrition products. The company’s enteral nutrition products supplies nutrients such as glucose, proteins, fats, electrolytes, and vitamin. It offers over the counter products include antiseptics for treating minor skin conditions and injuries, products for treating dry skin and products for treating athlete’s foot and ringworm. The company also provides contract manufacturing services. It develops various technologies for technologies for plastic containers, films, and formulations. Otsuka is headquartered in Naruto, Tokushima, Japan.

Otsuka Pharmaceutical Factory Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Otsuka Pharmaceutical Factory Inc, Medical Devices Deals, 2011 to YTD 2017 9
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 11
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 13
Otsuka Pharma Forms Joint Venture With Living Cell Technologies To Commercialize Diabecell 14
Licensing Agreements 16
Living Cell Technologies Enters into Licensing Agreement with Otsuka Pharma 16
OPF Enters into Licensing Agreement with Diatranz Otsuka 17
Equity Offering 18
Living Cell Technologies Completes Private Placement Of Shares For US$3.2 Million 18
Acquisition 19
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 19
Otsuka Techno and Nanjin Otsuka to Acquire 55% Stake in Changzhou Econ Drugs 20
Otsuka Techno and Otsuka Pharmaceutical Acquires 61.3% Stake in Nanjing Techbond Biomedical Material 21
Otsuka Pharmaceutical Factory Inc – Key Competitors 22
Otsuka Pharmaceutical Factory Inc – Key Employees 23
Otsuka Pharmaceutical Factory Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Aug 23, 2017: Otsuka OPV, the Vietnamese Subsidiary of Otsuka Pharmaceutical Factory Announces the Construction of a New factory for the Distribution of High Quality IV Solution Products 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Key Facts 2
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Otsuka Pharmaceutical Factory Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Otsuka Pharmaceutical Factory Inc, Medical Devices Deals, 2011 to YTD 2017 9
Otsuka Pharmaceutical Factory Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 11
Otsuka Pharma Factory Enters Into Distribution Agreement With Fresenius Kabi Japan For HES Products 13
Otsuka Pharma Forms Joint Venture With Living Cell Technologies To Commercialize Diabecell 14
Living Cell Technologies Enters into Licensing Agreement with Otsuka Pharma 16
OPF Enters into Licensing Agreement with Diatranz Otsuka 17
Living Cell Technologies Completes Private Placement Of Shares For US$3.2 Million 18
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 19
Otsuka Techno and Nanjin Otsuka to Acquire 55% Stake in Changzhou Econ Drugs 20
Otsuka Techno and Otsuka Pharmaceutical Acquires 61.3% Stake in Nanjing Techbond Biomedical Material 21
Otsuka Pharmaceutical Factory Inc, Key Competitors 22
Otsuka Pharmaceutical Factory Inc, Key Employees 23
Otsuka Pharmaceutical Factory Inc, Subsidiaries 24
Otsuka Pharmaceutical Factory Inc, Joint Venture 24

★海外企業調査レポート[Otsuka Pharmaceutical Factory Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務分析
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • McCain Foods Ltd:戦略・SWOT・企業財務分析
    McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fondation MEDINA-製薬・医療分野:企業M&A・提携分析
    Summary Fondation MEDINA (MEDINA) is a research organization that discovers biologically active molecules and drug candidates for unmet medical needs. The organization’s services include access to natural products libraries, drug discovery contract research with its high throughput screening platfor …
  • Swiber Holdings Ltd (AK3)-石油・ガス分野:企業M&A・提携分析
    Summary Swiber Holdings Limited (Swiber) is a provider of integrated offshore construction and support services to the oil and gas industry. The company offers offshore engineering, procurement, installation and construction (EPIC) and marine support services. Its offshore construction services incl …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • First Republic Bank:戦略・SWOT・企業財務分析
    First Republic Bank - Strategy, SWOT and Corporate Finance Report Summary First Republic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sun Hung Kai Properties Ltd:企業の戦略・SWOT・財務分析
    Sun Hung Kai Properties Ltd - Strategy, SWOT and Corporate Finance Report Summary Sun Hung Kai Properties Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • General Dynamics Corporation:企業の戦略・SWOT・財務情報
    General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aaron’s Inc:戦略・SWOT・企業財務分析
    Aaron's Inc - Strategy, SWOT and Corporate Finance Report Summary Aaron's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Zoo Digital Group plc (ZOO):企業の財務・戦略的SWOT分析
    Summary Zoo Digital Group Plc (ZOO) is a technology company that offers localization and media production services. It offers services such as subtitling, captioning, dubbing and digital distribution. The company's activities include providing a range of services to allow television and movie conten …
  • Quanta Services Inc (PWR):企業の財務・戦略的SWOT分析
    Quanta Services Inc (PWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • McDermott International, Inc.:企業の戦略・SWOT・財務情報
    McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report Summary McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Isuzu Motors Ltd (7202):企業の財務・戦略的SWOT分析
    Isuzu Motors Ltd (7202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hanwei Energy Services Corp (HE):石油・ガス:M&Aディール及び事業提携情報
    Summary Hanwei Energy Services Corp (Hanwei Energy) is a chemical company that develops, manufactures and distributes plastic fibre reinforced piping systems. The company’s products include anhydride and amine cured frp pipes, fittings, fixtures and flanges. It offers client solutions such as pre-te …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • One Call Care Management Inc:医療機器:M&Aディール及び事業提携情報
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc, is a healthcare technology provider that provides specialized cost containment services. The company offers diagnostics, dental, transport, complex home care, equipment and physical therapy, among others. It provides value a …
  • Essential Energy Services Ltd (ESN):企業の財務・戦略的SWOT分析
    Summary Essential Energy Services Ltd (Essential Energy) operates as an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipmen …
  • Hilton Worldwide Holdings Inc:企業のM&A・事業提携・投資動向
    Hilton Worldwide Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hilton Worldwide Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Bank Sinopac:企業の戦略・SWOT・財務分析
    Bank Sinopac - Strategy, SWOT and Corporate Finance Report Summary Bank Sinopac - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • TaiMed Biologics Inc (4147):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB-355, TMB-607 and TMB-571, among others. It offers TMB-355 which is a proprietary humanized ant …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆